NFE2L2 and Parkinson disease: Indeed, the “nuclear factor erythroid 2-related factor 2” (Nrf2) pathway, a master regulator of cellular defense and mitochondrial activity, can be overexpressed in PD patients’ PBMCs in proportion to the disease duration, suggesting a systemic defensive response to the PD clinical-pathological progression [213].